Lab
Bioreference Health, LLC
Bioreference Health, LLC was paid $117K by Medicaid between Jan 2018 and Sep 2024, across 37 billing codes. Its largest line is 87591, Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe — 15% of everything it billed.
33Billing provider infoBIOREFERENCE HEALTH, LLC
HOUSTON, TX 77054
HOUSTON, TX 77054
33aNPI1164975579assigned 08/02/2016
33bProvider typeClinical Medical Laboratory
28Total paid$117K
24GClaims17,851
24DCodes billed37
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#143 of 436
Median peer was paid$17K
This provider vs. median6.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 367 | $0.00 | |
| 2019 | 279 | $0.00 | |
| 2020 | 2,792 | $16K | |
| 2021 | 3,403 | $29K | |
| 2022 | 4,293 | $32K | |
| 2023 | 3,675 | $23K | |
| 2024incomplete | 3,042 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 15% | 1,286 | 1,245 | $17K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 15% | 1,280 | 1,241 | $17K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 10% | 842 | 815 | $12K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 9.3% | 1,261 | 1,236 | $11K |
| 80081 | 7.1% | 418 | 400 | $8K | |
| 80053 | Comprehensive metabolic panel | 4.5% | 1,177 | 1,036 | $5K |
| 87481 | 4.3% | 212 | 210 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.1% | 69 | 61 | $5K |
| 80050 | General health panel | 3.9% | 262 | 256 | $5K |
| 87512 | 3.7% | 263 | 260 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.5% | 1,260 | 1,198 | $4K |
| 80061 | Lipid panel | 3.1% | 687 | 669 | $4K |
25 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.8% | 1,122 | $3K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.6% | 528 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.4% | 688 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.9% | 254 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.8% | 772 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 41 | $1K |
| 86592 | <1% | 404 | $819.23 | |
| 82728 | <1% | 116 | $697.75 | |
| 87077 | <1% | 167 | $676.42 | |
| 87799 | <1% | 27 | $636.31 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 98 | $623.35 |
| 83540 | <1% | 152 | $394.08 | |
| 82607 | <1% | 30 | $214.97 | |
| 82746 | <1% | 29 | $195.97 | |
| 86803 | <1% | 68 | $180.67 | |
| 83550 | <1% | 37 | $174.58 | |
| 87088 | <1% | 94 | $152.22 | |
| 87186 | <1% | 64 | $136.08 | |
| 87070 | <1% | 26 | $129.80 | |
| 84439 | <1% | 30 | $117.34 | |
| 87340 | <1% | 16 | $77.12 | |
| 82950 | <1% | 40 | $63.22 | |
| 81001 | <1% | 28 | $36.10 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,495 | $0.00 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 508 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHMID, MICHAEL (SVP, CHIEF FINANCIAL OFFICER)
Parent organizationBIOREFERENCE HEALTH, LLC
| Provider | Location | Paid |
|---|---|---|
| Bioreference Health, LLC | Elmwood Park, NJ | $620.07M |
| Bioreference Health, LLC | Houston, TX | $8.87M |
| Florida Clinical Laboratory, INC | Melbourne, FL | $549K |
| Bioreference Health, LLC | Mineola, NY | $175K |
| Bioreference Health, LLC | Burbank, CA | $25K |
| Bioreference Health, LLC | Gaithersburg, MD | $8K |
| Bioreference Health, LLC | Hackensack, NJ | $22.86 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.